FOXM1 and its Oncogenic Signaling in Gastric Cancer

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|10|3|270-279

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.10, Iss.3, 2015-01, pp. : 270-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade

By      

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 2031-2036

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer

By            

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 1707-1716

Spandidos Publications

Access to resources Recommend Favorite

Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells

By                      

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 1858-1864

Spandidos Publications

Access to resources Recommend Favorite

Future roles for FoxM1 inhibitors in cancer treatments

By Adami Guy R   Ye Honggang  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 1-3

Future Medicine

Access to resources Recommend Favorite

Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 12, Iss. 3, 2017-09 ,pp. : 247-259

Bentham Science Publishers

Access to resources Recommend Favorite